News & Publications
Find our latest news and analysis here. From the daily Newsstand to the Quarterly Journal, we cover the full breadth of intellectual property law.
Written April 4, 2019
The patents disclose several methods of measuring a patient’s blood MPO level. The Court concluded that the claims were directed to the natural law that blood MPO levels correlate a patient’s level of myeloperoxidase (MPO), a naturally occurring protein that exists in higher levels in the blood of heart disease patients.
Highlight your brand at a premier intellectual property law event, webinar, podcast, or in one of our publications.
For rates, availability, or additional details, click here or contact:
American Intellectual Property Law Association (AIPLA)